Studies on 2-n-propyl-2(E)-pentenoate (Δ2(E)-valproate) in man
- 1 June 1992
- journal article
- editorial
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 14 (3) , 159-160
- https://doi.org/10.1007/bf01962709
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Pharmacological, toxicological and neurochemical effects of Δ2(E)-valproate in animalsInternational Journal of Clinical Pharmacy, 1992
- Single-dose tolerance and pharmacokinetics of 2-n-propyl-2(E)-pentenoate (Δ2(E)-valproate) in healthy male volunteersInternational Journal of Clinical Pharmacy, 1992
- Penetration of Valproate and its Active Metabolites into Cerebrospinal Fluid of Children with EpilepsyEpilepsia, 1988
- Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: Correlation with neural tube defect formation in the mouseTeratology, 1986
- The Hepatotoxicity of Valproic Acid and Its Metabolites in Rats. I. Toxicologic, Biochemical and Histopathologic StudiesHepatology, 1984
- Multiple sclerosis, HLA, and lymphocyte surface markersActa Neurologica Scandinavica, 1984
- The Toxicity of Metabolites of Sodium Valproate in Cultured HepatocytesThe Journal of Clinical Pharmacology, 1983
- Effects of sodium valproate in 100 children with special reference to weight.BMJ, 1981
- Sodium Valproate, Serum Level and Clinical Effect in Epilepsy: A Controlled StudyEpilepsia, 1979
- Sodium Di‐N‐Propylacetate (DPA) in the Treatment of Epilepsy:A ReviewEpilepsia, 1975